March 28, 2007Open Access

Reduction of Surgical Mortality and Morbidity in Diabetic Patients Undergoing Cardiac Surgery With a Combined Intravenous and Subcutaneous Insulin Glucose Management Strategy

Structured PICO

Does a combined IV and SC insulin strategy reduce surgical morbidity and mortality in diabetic patients undergoing cardiac surgery?

Population

Diabetic patients undergoing cardiothoracic (CT) surgery

Intervention

Combined intravenous (IV) insulin in the ICU and subcutaneous (SC) insulin outside the ICU

Comparator

3 days of IV insulin postoperatively

Outcome

Surgical morbidity and mortalityhard clinical

A combined IV and SC insulin strategy is a less costly and less nursing-intensive alternative that reduces surgical morbidity and mortality in diabetic patients after cardiac surgery.

Abstract

A combination of IV insulin (in the ICU) and SC insulin (outside the ICU), a less costly and less nursing-intensive therapy than 3 days of IV insulin postoperatively, results in a reduction of the increased surgical morbidity and mortality in diabetic patients after CT surgery.

KI fragen

Bookmark

View Full Paper